#echosens

Thiard News@F4F

@newsen.bsky.social

3 months ago

Echosens Secures Its Spot as a Top Place to Work in 2025 by The Boston Globe Echosens has been recognized by The Boston Globe as one of Massachusetts' Top Places to Work in 2025 for its commitment to employee growth and culture.

Echosens Secures Its Spot as a Top Place to Work in 2025 by The Boston Globe #United_States #Echosens #FibroScan #Westborough #Top_Places_to_Work

Thiard News@F4F

@newsen.bsky.social

6 months ago

FDA Accepts Echosens’ Intent Letter for Innovative Liver Disease Diagnostics Using FibroScan in Clinical Trials Echosens' FibroScan has received FDA approval to be used as a non-invasive endpoint in clinical trials for metabolic dysfunction-associated steatohepatitis.

FDA Accepts Echosens’ Intent Letter for Innovative Liver Disease Diagnostics Using FibroScan in Clinical Trials #USA #FDA_Approval #Echosens #FibroScan #Westborough

Thiard News@F4F

@newsen.bsky.social

6 months ago

FDA Acceptance Marks a Milestone for FibroScan® in Non-Invasive Liver Diagnostics Echosens celebrates FDA's acceptance of FibroScan® as a surrogate endpoint for MASH clinical trials, potentially transforming liver disease evaluation.

FDA Acceptance Marks a Milestone for FibroScan® in Non-Invasive Liver Diagnostics #USA #FDA_Approval #Echosens #FibroScan #Westborough

Thiard News@F4F

@newsen.bsky.social

6 months ago

FDA's Acceptance of Intent Letter Transforms Non-Invasive Liver Assessment with FibroScan® Echosens' FibroScan® has been recognized by the FDA as a potential replacement for liver biopsies in MASH clinical trials, marking a pivotal moment in non-invasive liver diagnostics.

FDA's Acceptance of Intent Letter Transforms Non-Invasive Liver Assessment with FibroScan® #USA #MASH #Echosens #Westborough #FibroScan®

Thiard News@F4F

@newsen.bsky.social

6 months ago

FDA Paves the Way for Non-Invasive Liver Diagnosis with FibroScan® in MASH Trials The FDA has recognized Echosens' FibroScan® as a probable surrogate endpoint for MASH clinical trials, transforming liver disease diagnosis and treatment.

FDA Paves the Way for Non-Invasive Liver Diagnosis with FibroScan® in MASH Trials #MASH #Echosens #FibroScan #Westborough

Thiard News@F4F

@newsen.bsky.social

6 months ago

Echosens and Novo Nordisk Partner to Enhance MASH Awareness and Diagnostic Methods Echosens and Novo Nordisk strengthen their partnership to improve awareness and early diagnosis of metabolic dysfunction-associated steatohepatitis (MASH), emphasizing non-invasive diagnostic solutions.

Echosens and Novo Nordisk Partner to Enhance MASH Awareness and Diagnostic Methods #United_States #MASH #Novo_Nordisk #Echosens #Westborough

Thiard News@F4F

@newsen.bsky.social

8 months ago

Echosens Joins Forces with United Digestive to Enhance Non-Invasive Liver Diagnostics Access Across Southeast USA Echosens partners with United Digestive to enhance access to non-invasive liver diagnostics in Georgia and Florida, improving early disease detection and tailored care.

Echosens Joins Forces with United Digestive to Enhance Non-Invasive Liver Diagnostics Access Across Southeast USA #United_States #Echosens #FibroScan #United_Digestive #Georgia_and_Florida

Thiard News@F4F

@newsen.bsky.social

9 months ago

Echosens and Boehringer Ingelheim Unite to Enhance MASH Health Solutions Echosens and Boehringer Ingelheim are strengthening their partnership to revolutionize the diagnosis and care of metabolic dysfunction-associated steatohepatitis (MASH), a pressing health concern worldwide.

Echosens and Boehringer Ingelheim Unite to Enhance MASH Health Solutions #Boehringer_Ingelheim #MASH #Echosens

Thiard News@F4F

@newsen.bsky.social

9 months ago

Echosens and Boehringer Ingelheim Team Up to Enhance MASH Care Echosens and Boehringer Ingelheim expand their partnership to tackle metabolic dysfunction-associated steatohepatitis (MASH) through early diagnosis and better care.

Echosens and Boehringer Ingelheim Team Up to Enhance MASH Care #USA #Paris #Boehringer_Ingelheim #MASH #Echosens

Thiard News@F4F

@newsen.bsky.social

9 months ago

Echosens and Boehringer Ingelheim Strengthen Partnership to Combat MASH Echosens and Boehringer Ingelheim expand their collaboration to enhance early diagnosis and treatment of MASH, addressing a critical health issue.

Echosens and Boehringer Ingelheim Strengthen Partnership to Combat MASH #Paris #France #Boehringer_Ingelheim #MASH #Echosens

Thiard News@F4F

@newsen.bsky.social

9 months ago

Echosens and Boehringer Ingelheim Expand Collaboration to Combat MASH Effectively Echosens and Boehringer Ingelheim enhance their partnership to tackle metabolic associated steatohepatitis (MASH), aiming for better diagnosis and treatment accessibility.

Echosens and Boehringer Ingelheim Expand Collaboration to Combat MASH Effectively #USA #Paris #Boehringer_Ingelheim #MASH #Echosens

Thiard News@F4F

@newsen.bsky.social

9 months ago

Echosens and Boehringer Ingelheim Expand Collaboration to Enhance MASH Diagnosis Echosens and Boehringer Ingelheim enhance their partnership to tackle the dangerous and underdiagnosed condition known as MASH, impacting millions worldwide.

Echosens and Boehringer Ingelheim Expand Collaboration to Enhance MASH Diagnosis #Paris #France #Boehringer_Ingelheim #MASH #Echosens

Thiard News@F4F

@newsen.bsky.social

9 months ago

Echosens and Boehringer Ingelheim Expand Long-Standing Partnership to Enhance MASH Diagnosis and Treatment Echosens and Boehringer Ingelheim are enhancing their long-standing collaboration to improve diagnosis and treatment of MASH, impacting over 250 million globally.

Echosens and Boehringer Ingelheim Expand Long-Standing Partnership to Enhance MASH Diagnosis and Treatment #Paris #France #Boehringer_Ingelheim #MASH #Echosens

Philippa Matthews

@pippa-matt.bsky.social

11 months ago

This project in #Uganda #Kenya & #SouthAfrica also highlights #liverhealth evaluation with #ultrasound. Big #equity concerns as such tools are key to clinical care but not available in many settings.
#fibroscan #echosens #hepatitis #HBV #KWTRP #UVRI @ahri-news.bsky.social
doi.org/10.6084/m9.f...

Thiard News@F4F

@newsen.bsky.social

1 year ago

Echosens Earns 2024 Top Place to Work Honor from The Boston Globe Recognized as a top workplace in Massachusetts, Echosens showcases vibrant culture and commitment to employee well-being impacting liver health.

Echosens Earns 2024 Top Place to Work Honor from The Boston Globe #United_States #Boston_Globe #Echosens #FibroScan #Westborough